Tenthpin
Ushering Data-Driven and Patient-Centric Digital Transformations

Who isn’t aware of this age-old saying!

While we were always advocates of this statement, it was only until recently that the phrase found a more commonplace in the modern pharma, life sciences, and healthcare industries. Considering that these sectors have been prominently clinician-centric until now, one might wonder, what took them so long to make a move from ‘cure’ to ‘prevent’?

The answer is digitalisation. The surging role of data and technology in medicine has been enabling the healthcare industry to make constant strides towards a patient-centric care delivery model. Riding on the bandwagon of this paradigm shift, now many life sciences companies—and their supply chain stakeholders—are seeking for ways to best support their current patient-centric and ‘preventive’ care model by incorporating advanced data-driven technologies at the centre of all the transformation efforts.

But all things considered, one of the fundamental weak links that the pharma industry is trying to address in its pursuit is improving the data integrity, quality, and accuracy that is critical for ensuring more precise drug development processes. Even to this day, the data generated by stakeholders of the clinical supply chain is stored across siloed systems. Its data, therefore, often go underutilised—if not completely untapped—for crucial decision-making. And even if life sciences organisations find a way to leverage the siloed data, they fall short in getting the whole picture because of the sheer complexity of collating holistic data from a slew of different systems spread across multiple participants of the clinical supply chain.

With a view to tackling this issue head-on, and steer the life sciences industry several years forward in terms of how they use data and data-driven technologies in the most effective way, Tenthpin cements its cornerstone. By helping its pharma and life sciences clients integrate databases and systems across the entire drug development and supply chain continuum, Tenthpin is freeing them from the shackles of data silos, facilitating their evolution into true data and technology-driven organisations. “At Tenthpin, we believe that the integrity of data—and the systems used to manage this data—is pertinent to enabling a patientcentric healthcare system. And we are here to make that happen,” opines Bernd Rosenkranz, partner at Tenthpin.

Especially when it comes to setting up clinical trials, which form a critical part of pharma research and development, it is imperative for companies to tighten the coordination and data-sharing between the different stakeholders involved in the process. Rather than having to painstakingly collate the relevant information from every other system and database leveraged by the stakeholders, what life sciences organisations need is an end-toend, comprehensive solution that can facilitate data-sharing in realtime, enabling organisations to seamlessly manage their internal and external processes with complete visibility—precisely the capabilities that Tenthpin’s intelligent clinical supply management (iCSM) solution brings to the table.

Tenthpin’s iCSM solution is the end-result of a co-innovation between SAP, Roche, and over 20 other industry participants (including pharma, CMO, and IRT software providers). As iCSM has the potential to seamlessly integrate with third-party infrastructures (of CMOs and 3PLs), pharma companies not only can ensure a centralised view of all crucial clinical data but also avail a tighter operation integration. Together with that, the solution also combines SAP’s cloud planning and analytics capabilities to streamline the clients’ entire clinical trial management value chain. The data integrity and analytical insights facilitated by iCSM also translates into intelligent, optimised decision-making during the clinical development process, assisting pharma companies in their shift towards precision medicine (with a significant reduction in side-effects).

At Tenthpin, we believe that the integrity of data—and the systems used to manage this data—is pertinent to enabling a patient-centric healthcare

Above all, Rosenkranz adds, “iCSM is part of an industrystandard solution, which means it is configurable to meet the varying operating models and requirements of different life sciences industry verticals, and therefore cater to different use case scenarios.”

Interestingly, the data generated from the clinical trials and clinical supply chain processes can be accessed through Tenthpin’s and SAP’s co-innovated batch release cockpit, where the relevant users can easily view detailed information any time they need— whether it is genealogy data, deviations list, list of country approvals, or inspection lists. Even the testing status, batch record review status, deviations status, shelf-life check, regulatory changes, and upstream release status can be viewed through the cockpit, eliminating the need to collect it from a hundred different siloed systems. Owing to this centralised repository of information, clients can even manage their compliance and regulatory needs without any hassle.

What’s more? Tenthpin is also making giant strides in streamlining the entire logistics operations involved throughout the development and distribution of drugs and vaccines, whether it is transporting batches overseas or across borders. The company’s clients benefit greatly from Tenthpin’s co-innovated cold chain management solution, which facilitates seamless tracking of critical vaccine or drug batches throughout the supply chain— through laboratories, drug manufacturers, wholesalers, hospitals, and ultimately to the patients. Since all the data is easily available at their fingertips, clients not only can ensure compliance with regulations but also overcome the many hurdles that occur during the logistics phase. Furthermore, clients can further use Tenthpin’s e-labeling solution to automatically label their products and maintain absolute consistency of relevant product information, which can contribute to brand integrity as well as patient safety.

“Our expertise also extends to cell and gene therapy, through our treatment management platform,” says Rosenkranz. Using this platform, relevant administrators from pharma and life sciences organisations can create and adjust processes across multiple connected systems. The integration with other systems also facilitates a clear visibility into various time-sensitive and highly scheduled tasks.

These robust solutions of Tenthpin are indeed propelling the pharma and life sciences industry one step closer to achieving complete digitalisation. Among the many success stories it has penned in the sector, there is one that stands out owing to the role Tenthpin played in streamlining its supply chain processes. This particular pharma client needed to transport a specific batch of vaccines from Germany to the U.S. for clinical trials. Normally, it would have taken at least six weeks, since the vaccines had to move through different stakeholders, with no easy way for the pharma company to track its batch. Having previous ties with Tenthpin, the client decided to utilise the company’s iCSM solution to integrate data from the multiple stakeholders. As the data was updated in real-time, it gave the client a bird’s eye view of the vaccines’ movement through the supply chain, enabling them to coordinate quickly and more efficiently. The end result? The batch of vaccines, which would have spent more than a month in transit, reached its destination within just a couple of days. Such an incredible success definitely speaks volumes about the competency of Tenthpin’s solution suite.

Today, owing to such accomplishments and contributions to the life sciences sector, Tenthpin has cemented its stature as a driving force in moving the industry to its digital future. In upcoming months, the company intends to strengthen collaboration with industry partners and further expand the functionality of its offerings. By growing its consortium of partners, Tenthpin is poised to revamp the entire value chain of drug development with data-driven technologies. Alongside this, the company is also looking forward to increasing its global presence. “By uplifting the data processes of the life sciences and pharma companies, we are headed in the right direction to attain a complete patient-centric care delivery model driven by preventive medicine,” concludes Rosenkranz.